SCHEMBL29664907

SCHEMBL29664907

CNC(=O)c1ncccc1Oc1ccc(NC(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 8/20 0.68
BRAF P15056 7/20 0.68
KDR P35968 7/20 0.68
RET P07949 3/20 0.68
CDK8 P49336 3/20 0.68
RIPK2 O43353 2/20 0.68
ABCB11 O95342 2/20 0.68
ABL1 P00519 2/20 0.68
HTR1A P08908 2/20 0.68
PDGFRB P09619 2/20 0.68
ADORA3 P0DMS8 2/20 0.68
KIT P10721 2/20 0.68
FGFR1 P11362 2/20 0.68
PDGFRA P16234 2/20 0.68
FLT1 P17948 2/20 0.68
MAOA P21397 2/20 0.68
EPHA1 P21709 2/20 0.68
TBXA2R P21731 2/20 0.68
EPHA2 P29317 2/20 0.68
TTK P33981 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1412957 1.00 RAF1 (0.68) RAF1BRAFKDRRETCDK8
SCHEMBL5635463 0.93 RAF1 (0.58) RAF1BRAFKDRRETCDK8
SCHEMBL2559430 0.90 BRAF (0.72) RAF1BRAFKDRRETCDK8
SCHEMBL30448225 0.89 BRAF (0.54) RAF1BRAFKDRRETCDK8
SCHEMBL6051249 0.88 BRAF (0.69) RAF1BRAFKDRRETCDK8
SCHEMBL28415556 0.84 BRAF (0.63) RAF1BRAFKDRRETCDK8
SCHEMBL31255796 0.84 BRAF (0.58) RAF1BRAFKDRRETCDK8
SCHEMBL16620824 0.83 KDR (0.65) RAF1BRAFKDRRETCDK8
SCHEMBL28896139 0.81 BRAF (0.49) RAF1BRAFKDRRETCDK8
Sorafenib SCHEMBL14739751 0.81 RAF1 (1.00) RAF1BRAFKDRRETCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113004183-B Sorafenib antitumor inhibition auxiliary compound and composition and application thereof 中山大学附属第三医院(中山大学肝脏病医院) 2023-03-14 CN disclosed
CN-114728000-A Novel pharmaceutical combination for the treatment of cancer 荷兰癌症研究所-安东尼·范·雷文虎克医院基金会 2022-07-08 CN disclosed